Reminder: Ordering arrangements for Inclisiran (Leqvio®)

Contractors are reminded that Inclisiran (Leqvio®) is available to order from AAH UK at a nominal charge of £45 per pack, as agreed within the commercial agreement between Novartis and NHS England for supply against NHS prescriptions only.  AAH UK was awarded the tender for supply of Inclisiran (Leqvio®) to primary care in England under a Solus distribution arrangement.

AAH UK has now updated its ordering systems to make it clear that their stock of Inclisiran (Leqvio®) is for NHS supplies only. Stock for private prescriptions (at the full list price) can be obtained by contacting Novartis Customer Care directly on 08457 419 442 or via e-mail commercial.team@novartis.com

Background to the inclusion of Inclisiran (Leqvio®) in Part VIIIC of the Drug Tariff

From September 2021, a new section (Part VIIIC) was included in the Drug Tariff setting out payment arrangements for products with a nominal price (i.e where the purchase price of the product is significantly lower than its NHS list price).

Products listed in Part VIIIC are available at nominal prices because of commercial deals in place between the manufacturer or supplier and the NHS England and NHS Improvement (NHSE&I) which allows manufacturers to supply a drug to the NHS at a reduced cost compared to its published NHS list prices as authored in the NHS Dictionary of Medicines and Devices (dm+d).

Part VIIIC currently outlines the reimbursement price of one product, Inclisiran (Leqvio®), under such a commercial arrangement.

Q.What can I do if Inclisiran cannot be obtained at the Part VIIIC list price?

Contractors should not expect to incur any additional charges or fees when ordering Inclisiran from AAH UK. The product will be available to order at the nominal charge of £45 per pack, as agreed within the commercial agreement between Novartis and NHSE&I. However, contractors who are unable to source products listed in Part VIIIC at or below the basic price, or who are the subjected to additional charges when purchasing the products listed in this Part, may request a review of the basic price and repayment of any additional costs incurred. The review requires the following steps to be taken:

  • If there are any issues with the supply, ordering and pricing of the product, contractors must contact AAH UK in the first instance.
  • This can be escalated to Novartis via the wholesaler if appropriate, and a resolution to all issues raised will be sought within 5 working days from receipt.
  • Should no resolution be identified by the suppliers within 5 working days of receipt, then contractors should escalate the issue to PSNC who will work in collaboration with NHSE&I and Novartis to seek a resolution to issues raised.
  • To support the handling of the review, contractors are required to submit evidence of any difficulties experienced including issues with pricing or supply. Any claims and supporting evidence will then be referred by PSNC to Department of Health and Social Care.

Following a successful review, where pricing issues are identified, any adjustments will be applied by the NHS Business Service Authority (NHSBSA) to the contractors account at the earliest possible payment date.

To escalate a pricing or supply issue with Inclisiran please contact comms.team@cpe.org.uk

Further Information

Inclisiran (Leqvio®) added to a new section of the Drug Tariff (Part VIIIC)

Discover how we are working to improve the outlook for community pharmacy at an event near you.

Click Here